Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation

BACKGROUND: Shenmai injection (SMI) has been used in the treatment of cardiovascular disease (CVD), such as heart failure, myocardial ischemia and coronary heart disease. It has been found to have efficacy on doxorubicin (DOX)-induced cardiomyopathy. The aims of this study were to explore the underl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Complement Med Ther
Hlavní autoři: Li, Lin, Yang, Dongli, Li, Jinghao, Niu, Lu, Chen, Ye, Zhao, Xin, Oduro, Patrick Kwabena, Wei, Chun, Xu, Zongpei, Wang, Qilong, Li, Yuhong
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158159/
https://ncbi.nlm.nih.gov/pubmed/32293408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-020-02905-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky